AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Scope & Guideline

Unraveling the complexities of lung health and disease.

Introduction

Delve into the academic richness of AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1040-0605
PublisherAMER PHYSIOLOGICAL SOC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1989 to 2024
AbbreviationAM J PHYSIOL-LUNG C / Am. J. Physiol.-Lung Cell. Mol. Physiol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address6120 Executive Blvd, Suite 600, Rockville, MD 20852, UNITED STATES

Aims and Scopes

The American Journal of Physiology-Lung Cellular and Molecular Physiology focuses on advancing the understanding of lung biology through a multidisciplinary approach that encompasses cellular and molecular physiology, pathophysiology, and therapeutic interventions. The journal emphasizes research that elucidates mechanisms underlying lung diseases and promotes knowledge that can lead to innovative treatments.
  1. Lung Cellular and Molecular Physiology:
    The journal publishes studies that investigate the fundamental cellular and molecular processes in lung physiology, including cellular signaling pathways, gene expression, and the role of various cell types in maintaining lung function.
  2. Pathophysiology of Lung Diseases:
    Research addressing the pathological mechanisms of lung diseases such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and acute respiratory distress syndrome (ARDS) is a core focus, providing insights into disease mechanisms and potential therapeutic targets.
  3. Respiratory Inflammation and Immunity:
    The journal covers research on the immune responses in the lung, including inflammation, immune cell interactions, and the effects of environmental factors such as allergens and pollutants on lung health.
  4. Innovative Therapeutic Approaches:
    Research on novel therapeutic strategies, including stem cell therapies, bioengineering, and pharmacological interventions aimed at treating lung diseases, is a significant area of interest.
  5. Translational Research:
    The journal emphasizes studies that bridge basic research and clinical applications, aiming to translate findings from the laboratory to the bedside to improve patient outcomes in lung health.
The American Journal of Physiology-Lung Cellular and Molecular Physiology has seen the emergence of several trending themes in recent publications, reflecting the dynamic nature of research in lung physiology and pathology. These themes highlight the journal’s commitment to addressing current challenges and innovations in the field.
  1. Impact of COVID-19 on Lung Health:
    There is a significant increase in research focusing on the effects of COVID-19 on lung physiology and pathology, including studies on acute lung injury, long-term pulmonary sequelae, and the interplay between COVID-19 and preexisting lung conditions.
  2. Role of Extracellular Vesicles:
    Research on the role of extracellular vesicles in lung health and disease is gaining traction, highlighting their potential as biomarkers and therapeutic targets in conditions such as COPD and pulmonary fibrosis.
  3. Sex Differences in Lung Disease:
    An emerging theme is the exploration of sex differences in lung physiology and disease response, recognizing the need to understand how biological sex influences lung health outcomes.
  4. Environmental and Lifestyle Factors:
    There is a growing emphasis on the impact of environmental exposures, such as pollution and e-cigarette use, on lung health, reflecting a broader interest in how lifestyle choices affect respiratory diseases.
  5. Stem Cell and Regenerative Medicine Approaches:
    Innovations in stem cell research and regenerative medicine aimed at repairing lung tissue and restoring function are increasingly featured, indicating a shift towards potential curative therapies.

Declining or Waning

While the journal maintains a robust focus on various aspects of lung physiology and pathology, certain themes appear to be declining in prominence based on recent publications. This shift may reflect evolving research priorities and emerging areas of interest.
  1. Basic Animal Models:
    There has been a noticeable decrease in studies utilizing basic animal models for lung research, as the field increasingly emphasizes translational research that directly relates to human health and disease.
  2. Non-invasive Techniques:
    Research employing traditional non-invasive measurement techniques for lung function and pathology seems to be waning, potentially replaced by advanced imaging and molecular techniques that offer higher resolution and specificity.
  3. Historical Perspectives on Lung Diseases:
    Papers focusing on historical perspectives or reviews of past research trends in lung diseases appear to be less frequent, indicating a shift towards more contemporary and forward-looking studies.

Similar Journals

Journal of Thoracic Disease

Connecting research and practice in thoracic health.
Publisher: AME PUBLISHING COMPANYISSN: 2072-1439Frequency: 12 issues/year

Welcome to the Journal of Thoracic Disease, a premier scholarly journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by AME PUBLISHING COMPANY in Hong Kong, this journal has established itself as a critical platform for the dissemination of innovative research and clinical advancements since its inception in 2009. With an impressive Q2 ranking in the Scopus category of Pulmonary and Respiratory Medicine, it is recognized for its contribution to the academic community, featuring a broad range of original research, reviews, and case studies that address contemporary challenges in thoracic disease management. The journal is committed to Open Access principles, ensuring that high-quality research is readily available to a global audience, further enhancing its impact factor and reach. Researchers, healthcare professionals, and students alike will find invaluable insights within its pages, making Journal of Thoracic Disease an essential resource for those invested in the respiratory health domain.

Physiological Reports

Advancing the Frontiers of Physiology
Publisher: WILEYISSN: 2051-817XFrequency: 24 issues/year

Physiological Reports is a pioneering open-access journal published by WILEY, dedicated to advancing the field of physiology through the dissemination of high-quality research. Since its inception in 2013, this journal has provided a platform for innovative studies in both general physiology and medical physiology, making significant contributions to our understanding of biological processes. With an impact factor that reflects its growing influence—as evidenced by its placement in the Q2 category for physiology and medical physiology in 2023—Physiological Reports is positioned as a vital resource for researchers and practitioners alike. The journal encourages the submission of diverse studies ranging from cellular mechanisms to systemic physiology, presenting a unique opportunity for authors to reach a global audience without access barriers. It has established a reputation for rigorous peer review and timely publication, ensuring that cutting-edge research is readily available to stimulate further inquiry and collaboration in the scientific community.

HEART & LUNG

Unveiling Innovations in Cardiac and Respiratory Care
Publisher: MOSBY-ELSEVIERISSN: 0147-9563Frequency: 6 issues/year

HEART & LUNG is a premier academic journal published by MOSBY-ELSEVIER, focusing on the critical intersections of cardiology, critical care, and respiratory medicine. Since its inception in 1973, the journal has established a significant reputation within the medical community, as evidenced by its impressive Q2 ranking in key categories such as Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine, and Pulmonary and Respiratory Medicine for the year 2023. With a dedicated readership comprising researchers, healthcare professionals, and students, HEART & LUNG serves as a vital platform for disseminating cutting-edge research, clinical innovations, and comprehensive reviews that influence practice standards and enhance patient care. While it currently does not offer Open Access options, readers can access a wealth of information pivotal to the advancement of medical knowledge and practice through conventional subscription. Explore the latest findings and contribute to the ever-evolving landscape of cardiovascular and respiratory health through this esteemed journal.

RESPIRATORY RESEARCH

Pioneering Insights for a Breath of Fresh Air
Publisher: BMCISSN: Frequency: 1 issue/year

RESPIRATORY RESEARCH is a leading open-access journal published by BMC, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2000, this journal has provided a vital platform for disseminating high-quality research, covering a broad spectrum of topics from basic science to innovative clinical practices in respiratory health. With an impressive impact factor and a Q1 ranking in the Pulmonary and Respiratory Medicine category, RESPIRATORY RESEARCH is recognized for its significant contribution to the literature, currently positioned at rank #19 out of 155 in the Scopus database, highlighting its relevance and influence within the medical community. The journal’s commitment to open access ensures that all articles are freely available to researchers, professionals, and students, fostering collaboration and knowledge sharing in the field. With its convergence years spanning from 2000 to 2024, RESPIRATORY RESEARCH remains at the forefront of respiratory medicine research, making it an essential resource for all stakeholders in this vital medical domain.

Pulmonology

Pioneering insights for a healthier tomorrow in pulmonology.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

Zeitschrift fur Pneumologie

Exploring New Frontiers in Pulmonary Science
Publisher: SPRINGER HEIDELBERGISSN: 2731-7404Frequency: 6 issues/year

Zeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.

RESPIRATORY MEDICINE

Transforming Knowledge into Clinical Practice
Publisher: W B SAUNDERS CO LTDISSN: 0954-6111Frequency: 12 issues/year

Respiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.

Canadian Journal of Respiratory Critical Care and Sleep Medicine

Pioneering research in respiratory health and intensive care.
Publisher: TAYLOR & FRANCIS INCISSN: 2474-5332Frequency: 4 issues/year

Welcome to the Canadian Journal of Respiratory Critical Care and Sleep Medicine, a prestigious peer-reviewed journal published by Taylor & Francis Inc. With an ISSN of 2474-5332 and an E-ISSN of 2474-5340, this journal serves as a vital platform for disseminating cutting-edge research in the fields of critical care, intensive care medicine, and pulmonary and respiratory medicine. Since its inception in 2017, the journal has established itself within the academic community, currently holding a Q2 ranking in Critical Care and Intensive Care Medicine and a Q3 ranking in Pulmonary and Respiratory Medicine for 2023. Although it operates under a standard access model, the journal remains committed to providing valuable insights and advancing knowledge through rigorous research articles, reviews, and case studies. Positioned in the heart of the United States, the journal aims to foster collaboration and innovation among healthcare professionals, researchers, and students dedicated to enhancing respiratory care and critical treatment protocols. Join us in exploring the dynamic intersection of research and practice that defines our mission.

Pulmonary Circulation

Advancing knowledge in pulmonary health.
Publisher: WILEYISSN: 2045-8932Frequency: 4 issues/year

Pulmonary Circulation is a leading open-access journal published by Wiley, focused on advancing the field of pulmonary and respiratory medicine. Established in 2011, the journal has garnered a prestigious reputation, achieving a Q2 ranking in 2023 among its category and ranking #70 out of 155 in Scopus within the specialty of Medicine – Pulmonary and Respiratory Medicine, reflecting its growing influence and relevance in the scientific community. With its commitment to delivering high-quality, peer-reviewed research, Pulmonary Circulation serves as a vital resource for researchers, clinicians, and students seeking to explore innovative ideas and findings in lung health, pulmonary vascular diseases, and therapeutic approaches. The journal has been open access since 2017, ensuring that groundbreaking research is accessible to a wider audience, thus promoting collaboration and knowledge exchange in this dynamic field. Located in the heart of the United States at 111 River St, Hoboken, NJ 07030-5774, the journal is dedicated to fostering advancements in pulmonary health and addressing real-world challenges facing patients globally.

Jornal Brasileiro de Pneumologia

Connecting researchers for a healthier tomorrow in respiratory care.
Publisher: SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIAISSN: 1806-3713Frequency: 6 issues/year

Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.